Preclinical In-vivo Imaging Market size and growth: The global Preclinical In-vivo Imaging market has been estimated at USD 714.17 million in 2018 and is projected to reach USD 944.95 million by 2023, ata CAGR of 5.6% during the forecast period.
Preclinical In-vivo Imaging Market overview:
Preclinical imaging (In-VIVO) is used in live animal research for drug development. Preclinical imaging is further used to monitor the treatment response for early indications of efficacy. The technological development of in vivo imaging provides an opportunity for studying disease at the molecular level in a quantitative way. In vivo imaging acts as a bridge between in vitro exploratory and in vivo clinical research which facilitates the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. The key disease areas targeted with in vivo preclinical imaging are cancers, autoimmune diseases, neurological disorders, and cardiovascular diseases. Use of preclinical imaging in cancer is about 70% which is followed by autoimmune diseases and neurological disorders which accounts for 36% and 32%, respectively.
To know more, read @ https://www.marketdataforecast.com/market-reports/preclinical-in-vivo-imaging-market
Market Drivers and Restraints:
Factors such as technological advances and an increase in the prevalence of chronic diseases such as cancer, cardiovascular diseases, rheumatoid arthritis, and neurological disorders are driving the market for preclinical images worldwide. According to the American Cancer Society, 14.1 million new cases of cancer and 8.2 million cancer deaths were diagnosed in 2012. Technological developments such as the "Aspect's M2", a preclinical imaging product developed by Aspect the images, are used for the development of medicines, without the cost, complexity and technical burden of traditional MRI systems. Other factors, such as the growing demand for non-invasive imaging techniques and public funding of research and development activities, would feed the preclinical imaging market. However, the growth of the preclinical image market is hampered by factors such as the high price of the product that reduces adoption rates in academic institutions and the limited number of applications of each modality, which discourages the sale of products.
Report segmented as:
By Modality:
• Optical Imaging
o Bioluminescence/Fluorescence Imaging Systems
o Standalone Fluorescence Imaging Systems
o Optical + X-Ray/Optical + CT Imaging Systems
• Nuclear Imaging
o Micro-PET Systems (Standalone PET, PET/CT, and PET/MRI)
o Micro-SPECT Systems (Standalone SPECT, SPECT/CT, and SPECT/MRI)
o Tri-modality (PET/SPECT/CT) Imaging Sytems
• Micro-MRI
• Micro-CT
• Micro Ultrasound
• Photoacoustic
• Magnetic Particle Imaging Systems
By Reagent:
• Optical Imaging Reagents
o Bioluminescent Reagents
o Fluorescent Imaging Reagents
• Nuclear Imaging Reagents
o Preclinical PET Tracers
o Preclinical SPECT Probes
• MRI Contrast Agents
• CT Contrast Agents
View a sample and decide @ https://www.marketdataforecast.com/market-reports/preclinical-in-vivo-imaging-market/request-sample
Geographical segmentation:
Geographically, North America dominates the preclinical imaging market due to the rapid adoption of several types of modalities by end-user, technological advancement, growth in prevalence of chronic diseases such as cancer, cardiovascular disease, and others. According to the National Cancer Institute, about 1,685,210 new cases of cancer are likely to be diagnosed in the U.S. and 595,690 people are estimated to die from the disease by 2016 end. Europe and the Asia Pacific follow the North America market. Europe is the second largest market for preclinical imaging due to growing health care awareness among people and an increasing number of research and development activities. The Asia Pacific is expected to grow at a higher rate due to rise in a number of population, increase in opportunity for clinical and preclinical studies in low cost, and government support for research and development activities.
Key Market Players:
Major players operating in this market include Bruker Corporation, MR Solutions, PerkinElmer Inc., TriFoil Imaging, FUJIFILM Holdings America Corporation, Mediso Ltd., Miltenyi Biotec, Aspect Imaging, and MILabs B.V.
The Scope of the report:
The report offers a comprehensive examination of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along with this, the factors influential in influencing the market dynamics and trends discussed in detail at the product level. Further, the performance of the market at the regional and country-level had assessed, and the prospects with colossal growth potential identified and debated.
Check for discount: https://www.marketdataforecast.com/market-reports/preclinical-in-vivo-imaging-market/discount

About Us:
Market Data Forecast is a firm working in the areas of market research, business intelligence and research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: [email protected]
Tel: +1-888-702-9626
Website: https://www.marketdataforecast.com/